This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceuticals. Its structure, featuring a trifluoromethyl group and an amino acid moiety, makes it valuable for developing drugs targeting neurological disorders, such as epilepsy and anxiety. It is also explored in the creation of enzyme inhibitors, particularly those involved in metabolic pathways, due to its ability to mimic natural substrates. Additionally, its chiral nature allows for the development of enantiomerically pure compounds, enhancing the efficacy and specificity of therapeutic agents. Research is ongoing to explore its potential in treating inflammatory diseases and cancer.